--2025/Q1-- / 1.211M--
--2024/Q4-- / 490.000K--
--2024/Q3439.000K / 1.645M--
--2024/Q28.897M / 863.120K--
--2024/Q11.252M / 1.018M--
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 56.830
- +0.080+0.14%
Close Dec 20 16:00 ET
- 56.830
- 0.0000.00%
Post 16:11 ET
3.33BMarket Cap-48.57P/E (TTM)
59.720High55.630Low1.25MVolume56.370Open56.750Pre Close71.73MTurnover2.83%Turnover RatioLossP/E (Static)58.63MShares71.71052wk High5.08P/B2.51BFloat Cap7.79052wk Low--Dividend TTM44.20MShs Float71.710Historical High--Div YieldTTM7.21%Amplitude5.650Historical Low57.297Avg Price1Lot Size
Janux Therapeutics Key Stats
Janux Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Janux Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data